Stephen Y. Chan
Nottingham, ENG NG51PB, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers.
Journal: Theranostics
Published: August 03, 2020
PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers.
Journal: Cancer letters
Published: August 01, 2019
Dopamine and cAMP-regulated phosphoprotein 32 kDa (DARPP-32) and survival in breast cancer: a retrospective analysis of protein and mRNA expression.
Journal: Scientific reports
Published: March 25, 2019
High mobility group protein B1 is a predictor of poor survival in ovarian cancer.
Journal: Oncotarget
Published: January 06, 2017
RECQL4 helicase has oncogenic potential in sporadic breast cancers.
Journal: The Journal of pathology
Published: October 22, 2015
Calpain-1 is associated with adverse relapse free survival in breast cancer: a confirmatory study.
Journal: Histopathology
Published: August 26, 2015
The clinical usefulness of DNA aneuploidy in borderline ovarian tumours.
Journal: Onkologie
Published: October 06, 2012
The prognostic and predictive power of redox protein expression for anthracycline-based chemotherapy response in locally advanced breast cancer.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: April 07, 2012
Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer.
Journal: Journal of cellular and molecular medicine
Published: March 23, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026